[Federal Register Volume 70, Number 138 (Wednesday, July 20, 2005)]
[Notices]
[Page 41772]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-14294]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 1999N-1075] (formerly 99N-1075)


Quantitative Risk Assessment on the Public Health Impact of 
Vibrio parahaemolyticus in Raw Oysters; Notice of Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
meeting to present the ``Quantitative Risk Assessment on the Public 
Health Impact of Vibrio parahaemolyticus in Raw Oysters.'' This public 
meeting is intended to provide clarification about the results of the 
risk assessment and information on how the risk assessment may be 
utilized. Stakeholders will have an opportunity to ask questions about 
the risk assessment. Questions may also be submitted in advance of the 
public meeting (see Contact section of this document). Elsewhere in 
this issue of the Federal Register, FDA is announcing the availability 
of the risk assessment that is being presented at this public meeting.
    Date and Time: The meeting will be held on August 13, 2005, from 12 
noon to 3 p.m.
    Location: The meeting will be held at the Grand Hotel Marriot 
Resort, One Grand Blvd., Point Clear, AL 36564.
    Contact: Melissa Ellwanger, Center for Food Safety and Applied 
Nutrition (HFS-417), Food and Drug Administration, 5100 Paint Branch 
Pkwy., College Park, MD 20740, 301-436-1401, FAX: 301-436-2599, e-mail: 
[email protected].
    Registration and Requests for Oral Presentation: Send registration 
information (including name, title, firm name, address, telephone, and 
fax number), and written materials to the contact person by August 10, 
2005. Interested persons may present data, information, or views orally 
or in writing, on the issue. If you desire to make a formal oral 
presentation, you should notify the contact person before August 10, 
2005, and be prepared to give a brief description of the general nature 
of the information you wish to present. Time allotted for each 
presentation may be limited.
    If you need special accommodations due to a disability, please 
contact Melissa Ellwanger at least 7 days in advance of the meeting.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page.

    Dated: July 8, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-14294 Filed 7-18-05; 8:45 am]
BILLING CODE 4160-01-S